thioctic acid has been researched along with alloxan in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertrand, M; Charton, Y; Fouquier-d'Hérouël, MV; Ginot, YM; Goldstein, S; Guillonneau, C; Lestage, P; Lockhart, B | 1 |
| Jiang, J; Larrick, JW; Wang, Y; Yu, P; Zeng, X; Zhang, Z | 1 |
| Ajith, TA; Janardhanan, KK; Krishnan, CV; Sudheesh, NP | 1 |
| Miroshnichenko, IIu; Rassokhina, LM; Volchegorskiĭ, IA | 2 |
| Miroshnichenko, IY; Rassokhina, LM; Volchegorskii, IA | 1 |
6 other study(ies) available for thioctic acid and alloxan
| Article | Year |
|---|---|
Synthesis and pharmacological evaluation of new 1,2-dithiolane based antioxidants.
Topics: Alloxan; Animals; Antioxidants; Body Temperature; Drug Evaluation, Preclinical; Hyperglycemia; Lipid Peroxidation; Male; Mice; Molecular Structure; Morpholines; Oxidative Stress; tert-Butylhydroperoxide; Thioamides; Thiocarbamates; Thioctic Acid | 2003 |
Hypoglycemic and beta cell protective effects of andrographolide analogue for diabetes treatment.
Topics: Alloxan; Animals; Blood Glucose; Cytoprotection; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Diterpenes; Fasting; Glucose Transporter Type 4; Hypoglycemic Agents; Immunohistochemistry; Insulin; Insulin-Secreting Cells; Mice; Thioctic Acid | 2009 |
Palladium-α-lipoic acid complex attenuates alloxan-induced hyperglycemia and enhances the declined blood antioxidant status in diabetic rats.
Topics: Alloxan; Animals; Antioxidants; Blood Glucose; Catalase; Diabetes Mellitus, Experimental; Glutathione; Glutathione Peroxidase; Male; Palladium; Rats; Rats, Inbred Strains; Superoxide Dismutase; Thioctic Acid | 2011 |
[Cerebroprotective effect of 3-oxypyridine and succinic acid derivatives in acute phase of alloxan-induced diabetes mellitus in rats].
Topics: Alloxan; Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Disease Models, Animal; Female; Hippocampus; Learning; Lipid Metabolism; Lipid Peroxidation; Male; Meglumine; Motor Activity; Neurons; Neuroprotective Agents; Nootropic Agents; Picolines; Pyridines; Rats; Succinates; Succinic Acid; Thioctic Acid | 2011 |
[Antihypoxic effect of 3-hydroxypyridine and succinic acid derivatives and their nootropic action in alloxan diabetes].
Topics: Alloxan; Animals; Conditioning, Classical; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Relationship, Drug; Female; Hyperglycemia; Hyperlipidemias; Hypoxia; Male; Meglumine; Mice; Nootropic Agents; Picolines; Pyridines; Rats; Succinates; Thioctic Acid | 2011 |
Cerebroprotective effects of emoxipin, reamberin, and mexidol in alloxan diabetes.
Topics: Alloxan; Animals; Astrocytes; Cerebral Cortex; Diabetes Mellitus, Experimental; Diencephalon; Female; Hippocampus; Hyperglycemia; Male; Meglumine; Neurons; Neuroprotective Agents; Oligodendroglia; Paraventricular Hypothalamic Nucleus; Picolines; Rats; Succinates; Thioctic Acid | 2013 |